Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bodisen Biotech Sees Record 4th Quarter Earnings.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- Bodisen Biotech, Inc., (stock symbol: BBOI, website: www.bodisen.com) sees record 4th quarter earnings ending December 31, 2004.

Bodisen Biotech, a Delaware corporation A Delaware corporation is a corporation chartered in the U.S. state of Delaware. Delaware is well known as a corporate haven, and thus, over 50% of US publicly-traded corporations and 58% of the Fortune 500 companies are incorporated in the state. , is a profitable biotech company with proprietary technologies for developing, manufacturing and marketing environmentally friendly Environmentally friendly, also referred to as nature friendly, is a term used to refer to goods and services considered to inflict minimal harm on the environment.[1]  organic agricultural products for the Chinese markets.

Using proprietary technologies, Bodisen sells over 60 packaged products, broken down into 3 product categories: Organic Compound Fertilizer; Organic Liquid Fertilizer; and Pesticides & Insecticides insecticides, chemical, biological, or other agents used to destroy insect pests; the term commonly refers to chemical agents only. Chemical Insecticides
. Bodisen's organic fertilizers can be absorbed by plants within 48 hours while enriching soil conditions without the damaging effects associated with chemical fertilizers.

About Bodisen Biotech, Inc.

Bodisen is headquartered in Shaanxi, China, an agricultural hub of China and the economic gateway to the western regions of China. The Bodisen brand is a highly respected organic brand in China. Its "green" products support the mandate of the Chinese national government to increase crop yields for the purpose of decreasing China's dependency on food imports. Bodisen's products enjoy brand recognition and a price premium over competitive brands in China. With distribution in 20 provinces and an expanding geographic footprint, Bodisen is well positioned to take advantage of the growing demand for organic bio agricultural products in China.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Statement

This press release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. These statements are based on the current expectations or beliefs of Bodisen Biotech, Inc. management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 14, 2004
Words:265
Previous Article:Zix Corporation Selected by Four Regional Healthcare Facilities for Email Protection Services.
Next Article:Viyya Technologies Launches Interactive Website to Support Product Release.



Related Articles
Bodisen Biotech Receives $4.2 Million in Contracts, Sees Strong 3rd Quarter Financial Performance.
Bodisen Biotech Sees Record 3rd Quarter Earnings, Received $4.2 Million in Contracts.
The SEC Declared Effective Bodisen Biotech's Recent SB-2 Registration Statement and Bodisen Successfully Hosts Global Fund Managers in Yang Ling.
Bodisen Biotech, Inc. Will Report Record 3rd Quarter Earnings, Bodisen Makes Strategic Investment into Chinese Natural Gas Company.
Bodisen Biotech, Inc. Will Announce Record 3rd Quarter Earnings in the Morning of November 3, 2005 Before Market Opens.
Bodisen Biotech Announces 3rd Quarter Earnings of $0.22 per Share, 94% Increase in Revenue and 80% Increase in Net Income; Before a One Time...
Bodisen Biotech Signs US$43 Million in Contracts, Sees Record Earnings for 2006 and Continued Favorable Market Environment; Company Updates Growth...
Bodisen Biotech Sees Record 1st Quarter Net Income, Company Provides Guidance for Accelerated Sales and Earnings Growth in 2006.
Bodisen Biotech Reports Record First Quarter Earnings; Year-Over-Year Revenue Growth of 124%, Net Income Up 200%.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles